Search by Drug Name or NDC
NDC 50201-0421-02 Bromo Seltzer 1000; 325; 1916 mg/1; mg/1; mg/1 Details
Bromo Seltzer 1000; 325; 1916 mg/1; mg/1; mg/1
Bromo Seltzer is a ORAL TABLET, EFFERVESCENT in the HUMAN OTC DRUG category. It is labeled and distributed by Tower Laboratories Ltd. The primary component is ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE.
Product Information
| NDC | 50201-0421 |
|---|---|
| Product ID | 50201-0421_f0306b64-e6f7-476c-e053-2a95a90a2576 |
| Associated GPIs | 64109902110820 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Bromo Seltzer |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ASPIRIN, SODIUM BICARBONATE, CITRIC ACID |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Active Ingredient Strength | 1000; 325; 1916 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE |
| Labeler Name | Tower Laboratories Ltd |
| Pharmaceutical Class | Acidifying Activity [MoA], Alkalinizing Activity [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cyclooxygenase Inhibitors [MoA], Decreased Coagulation Factor Ac |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part343 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50201-0421-02 (50201042102)
| NDC Package Code | 50201-0421-2 |
|---|---|
| Billing NDC | 50201042102 |
| Package | 10 POUCH in 1 CARTON (50201-0421-2) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| Marketing Start Date | 2012-07-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |